00718.HK
Tai United Holdings Limited
HKSE · Healthcare · Medical - Distribution · HK
HKD 0.03
+6.67%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 150.9M | 125.1M | 121.8M | 211.8M | 159.7M |
| Cost of Revenue | 58.3M | 71.2M | 44.6M | 156.7M | 88.2M |
| Gross Profit | 92.6M | 53.8M | 77.2M | 55.1M | 71.5M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 47.6M | 41.4M | 33.6M | 23.1M | 39.1M |
| General & Admin Expense | 6.9M | — | 31.7M | 18.6M | 9.5M |
| Selling & Marketing Expense | 1.0M | — | 2.4M | 4.5M | 29.5M |
| Other Expenses | 39.4M | 94.6M | — | 362.4M | (4.1M) |
| Total Operating Expenses | 87.0M | 136.0M | 33.6M | 385.4M | 35.0M |
| Cost and Expenses | 145.3M | 207.3M | 78.1M | 542.2M | 184.9M |
| Operating Income (EBIT) | 5.6M | (82.2M) | 43.6M | (330.4M) | (705.8M) |
| Non-Operating | |||||
| Interest Income | — | 1.1M | 877.0K | 2.3M | 2.2M |
| Interest Expense | 77.8M | 154.6M | 163.5M | 173.1M | 178.2M |
| Net Interest Income | (196.4M) | (153.5M) | (162.6M) | (170.8M) | (175.9M) |
| Other Non-Op Income/Expense | (488.4M) | (302.4M) | (948.9M) | (1.0B) | (899.9M) |
| Non-Operating Income (excl Interest) | 28.5M | — | 62.2M | 1.2B | — |
| EBT (Pre-Tax Income) | (482.9M) | (384.6M) | (905.3M) | (1.4B) | (1.6B) |
| Income Tax Expense | 26.8M | (13.4M) | (145.6M) | (197.4M) | (150.7M) |
| Bottom Line | |||||
| Net Income | (459.8M) | (371.9M) | (760.3M) | (1.2B) | (1.5B) |
| Earnings from Cont. Ops | (458.8M) | (371.2M) | (759.7M) | (1.2B) | (1.5B) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (459.8M) | (371.9M) | (760.3M) | (1.2B) | (1.5B) |
| Per Share | |||||
| Basic EPS | (HK$0.09) | (HK$0.07) | (HK$0.14) | (HK$0.22) | (HK$0.28) |
| Diluted EPS | (HK$0.09) | (HK$0.07) | (HK$0.14) | (HK$0.22) | (HK$0.28) |
| Revenue Per Share | HK$0.03 | HK$0.02 | HK$0.02 | HK$0.04 | HK$0.03 |
| Shares | |||||
| Basic Shares Outstanding | 5.2B | 5.3B | 5.3B | 5.3B | 5.3B |
| Diluted Shares Outstanding | 5.2B | 5.3B | 5.3B | 5.3B | 5.3B |
| Profitability Metrics | |||||
| EBITDA | (19.2M) | (78.2M) | (734.4M) | (1.2B) | (1.4B) |
| D&A | 3.8M | 4.0M | 7.4M | 8.3M | 9.7M |
| EBIT | (22.9M) | (82.2M) | (741.9M) | (1.2B) | (1.4B) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026